IMPaCT: A Pilot Randomized Trial of an Intervention to Reduce Preterm Birth Among Non-Hispanic Black Patients at High Risk.

Sarahn M Wheeler Kelley E C MassengaleThelma A FitzgeraldTracy TruongTruls ØstbyeAmy CorneliGeeta K Swamy

Published in: Health equity (2022)

The intervention is feasible and acceptable. Larger, appropriately powered studies are needed to assess whether the intervention will decrease PSA and reduce preterm birth. This trial was registered with ClinicalTrials.gov (NCT04933812).

Keyphrases

preterm birth
randomized controlled trial
low birth weight
gestational age
study protocol
end stage renal disease
prostate cancer
phase iii
clinical trial
newly diagnosed
phase ii
chronic kidney disease
prognostic factors
open label
preterm infants
patient reported outcomes
case control